HNB
BRLI

Huntington National Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Huntington National Bank’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,183
Closed -$77K – 1868
2016
Q1 		$77K Buy
+2,183
New +$77K ﹤0.01% 994
2015
Q2 		– Sell
-2,183
Closed -$77K – 1880
2015
Q1 		$77K Hold
2,183
– – ﹤0.01% 998
2014
Q4 		$70K Buy
+2,183
New +$63.1K ﹤0.01% 1025
2014
Q1 		– Sell
-2,313
Closed -$59K – 1775
2013
Q4 		$59K Sell
2,313
-527
-19% -$16.2K ﹤0.01% 1050
2013
Q3 		$85K Sell
2,840
-492
-15% -$13.7K ﹤0.01% 935
2013
Q2 		$96K Buy
+3,332
New +$91.8K ﹤0.01% 868

Huntington National Bank's BRLI Position: Q2 2016 in Review

Huntington National Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2016, closing a stake of 2,183 shares — an estimated $77K sold.

Huntington National Bank first reported a position in BRLI in Q2 2013 and held it in 6 quarters. The position peaked at $96K in Q2 2013. 0 funds tracked by Wall St. Rank hold BRLI as of Q2 2016.

  • Huntington National Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2016 after selling out during the quarter.
  • Huntington National Bank sold 2,183 BIO-REFERENCE LABS INC-NEW- shares in Q2 2016, an estimated $77K.
  • Huntington National Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 6 quarters.
  • Huntington National Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $96K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2016.

Based on Huntington National Bank's 13F filing for Q2 2016, filed 25 Jul 2016.